EUVIMEDSkopri EUVIMED
Crossref

LCP‐Tacrolimus Extended‐Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients

Esther K Bae iD, Mary Moss Chandran iD, Melanie D Everitt iD, Eric Benz iD, Margret Bock iD

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15417 ↗

At a glance

Journal article in Clinical Transplantation, 2024. Written by Esther K Bae and 4 co-authors. Institution: Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA. Major MEDLINE topics: Tacrolimus, Immunosuppressive Agents, Organ Transplantation, Graft Rejection. 18 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Introduction

Limited published experience describes once daily, extended‐release tacrolimus (LCP‐Tac) use in pediatric solid organ transplantation (SOT), particularly nonrenal SOT. LCP‐Tac can simplify immunosuppression (IS) regimens, minimize immediate release‐tacrolimus (IR‐Tac)‐associated adverse effects, and promote adherence. This study describes the successful use of LCP‐Tac in adolescent and young adult (AYA) SOT populations.

Methods

A single‐center, retrospective chart review of AYA SOT recipients (age < 25 years) converted from IR‐Tac to LCP‐Tac. Graft survival, biopsy‐proven acute rejection (BPAR), infection rates, estimated glomerular filtration rate (eGFR), and pill burden were assessed at five time points postconversion (1, 3, 6, 12, and 24 months). Intrapatient variability of tacrolimus, as assessed by coefficient of variability (CV%), was also analyzed.

Results

Twenty‐nine AYA SOT recipients (19 heart, 6 kidney, and 4 liver) were converted to LCP‐Tac, with a median age of 17.4 years at conversion. Conversion, mainly due to perceived or identified medication nonadherence, occurred at a median of 5.4 years posttransplant. No graft loss occurred within 24 months of conversion, and BPAR incidence rate was consistent with previous reports for these populations. Only one patient experienced CMV infection. Renal function remained stable postconversion.

Conclusion

Successful conversion from IR‐Tac to LCP‐Tac was demonstrated in AYA heart, kidney, and liver transplant recipients. These AYA SOT recipients experienced reduced pill burden and improved tacrolimus trough concentration variability. However, the impact on medication adherence warrants further investigation. Future research should explore the targeted use of LCP‐Tac to enhance IS tolerability and medication adherence in young SOT populations.

Subjects

MeSH terms (MEDLINE)

TacrolimusImmunosuppressive AgentsOrgan TransplantationGraft RejectionDelayed-Action PreparationsGraft SurvivalTransplant RecipientsHumansAdolescentMaleFemaleRetrospective StudiesYoung AdultFollow-Up StudiesAdultPrognosisRisk FactorsGlomerular Filtration RateKidney Function TestsDrug Monitoring

Author keywords

adolescentextended‐release tacrolimusheart transplantimmunosuppressionkidney transplantliver transplantpediatricyoung adult

Substances

TacrolimusImmunosuppressive AgentsDelayed-Action Preparations

Authors and institutions

  • Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Pharmacy, UNC Health, Chapel Hill, North Carolina, USA.
  • Heart Institute, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Nephrology, Children's Hospital Colorado, Aurora, Colorado, USA.

ORCID profiles: Esther K Bae, Mary Moss Chandran, Melanie D Everitt, Eric Benz, Margret Bock

Cite

APA

Bae, E. K., Chandran, M. M., Everitt, M. D., Benz, E., & Bock, M. (2024). LCP‐Tacrolimus Extended‐Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15417

Vancouver

Bae EK, Chandran MM, Everitt MD, Benz E, Bock M. LCP‐Tacrolimus Extended‐Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients. Clinical Transplantation. 2024. doi:10.1111/ctr.15417

BibTeX
@article{Bae2024,
  author = {Bae, Esther K and Chandran, Mary Moss and Everitt, Melanie D and Benz, Eric and Bock, Margret},
  title = {LCP‐Tacrolimus Extended‐Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15417}
}
Start for free →